Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 316

1.

Cutaneous squamous cell carcinoma. Italian guidelines by SIDeMaST adapted to and updating EADO/EDF/EORTC guidelines.

Peris K, Alaibac M, Argenziano G, Di Stefani A, Fargnoli MC, Frascione P, Gualdi G, Longo C, Moscarella E, Naldi L, Pellacani G, Pimpinelli N, Quaglino P, Salgarello M, Sollena P, Valentini V, Zalaudek I, Calzavara Pinton PG; Italian Group of Dermato-oncology (GIDO) of SIDeMaST.

G Ital Dermatol Venereol. 2018 Jun 11. doi: 10.23736/S0392-0488.18.06093-5. [Epub ahead of print] No abstract available.

PMID:
29898593
2.

Survey of cutaneous adverse reactions to targeted cancer therapies: value of dermatological advice.

Damiani G, Manganoni A, Cazzaniga S, Naldi L; OncoSkin working group.

G Ital Dermatol Venereol. 2018 May 11. doi: 10.23736/S0392-0488.18.06033-9. [Epub ahead of print]

PMID:
29756421
3.

Validation of a visual-aided questionnaire for the self-assessment of hidradenitits suppurativa.

Cazzaniga S, Naldi L, Damiani G, Atzori L, Patta F, Guidarelli G, Bettoli V.

J Eur Acad Dermatol Venereol. 2018 May 5. doi: 10.1111/jdv.15050. [Epub ahead of print]

PMID:
29729101
4.

Cumulative exposure to biologics and risk of cancer in psoriasis patients: A meta-analysis of Psonet studies from Israel, Italy, Spain, United Kingdom and Republic of Ireland.

Garcia-Doval I, Descalzo MA, Mason KJ, Cohen AD, Ormerod AD, Gómez-García FJ, Cazzaniga S, Feldhamer I, Ali H, Herrera-Acosta E, Griffiths CEM, Stern R, Naldi L; Psonet Network.

Br J Dermatol. 2018 May 3. doi: 10.1111/bjd.16715. [Epub ahead of print]

PMID:
29723914
5.

Prevalence of contact allergy to metals in the European general population with a focus on nickel and piercings: The EDEN Fragrance Study.

Schuttelaar MLA, Ofenloch RF, Bruze M, Cazzaniga S, Elsner P, Gonçalo M, Naldi L, Svensson Å, Diepgen TL.

Contact Dermatitis. 2018 Jul;79(1):1-9. doi: 10.1111/cod.12983. Epub 2018 Apr 10.

PMID:
29635802
6.

Biological treatment for psoriasis and the risk of herpes zoster: Results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR).

Shalom G, Naldi L, Lebwohl M, Nikkels A, de Jong EMGJ, Fakharzadeh S, Goyal KG, Srivastava B, Langholff W, Galindo C, Cohen AD.

J Dermatolog Treat. 2018 Apr 5:1-20. doi: 10.1080/09546634.2018.1445193. [Epub ahead of print]

PMID:
29619848
7.

Patient-dermatologist agreement in psoriasis severity, symptoms and satisfaction: results from a real-world multinational survey.

Griffiths CEM, Augustin M, Naldi L, Romiti R, Guevara-Sangines E, Howe T, Pietri G, Gilloteau I, Richardson C, Tian H, Jo SJ.

J Eur Acad Dermatol Venereol. 2018 Mar 10. doi: 10.1111/jdv.14937. [Epub ahead of print]

PMID:
29524271
8.

Gender differences in genital lichen sclerosus.

Virgili A, Borghi A, Cazzaniga S, DI Landro A, Naldi L, Minghetti S, Fierro MT, Verrone A, Caproni M, Micali G, Gaspari V, Papini M, DI Lernia V, Germi L, Girolomoni G, Belloni Fortina A, Cannavò SP, Bilenchi R, Corazza M; GLS Italian Study Group.

G Ital Dermatol Venereol. 2018 Jan 24. doi: 10.23736/S0392-0488.17.05819-9. [Epub ahead of print]

PMID:
29368855
9.

Biologic treatment for psoriasis and cancer: an increased risk for most cancers could not be ruled out.

Naldi L.

Br J Dermatol. 2018 Jan;178(1):19. doi: 10.1111/bjd.16067. No abstract available.

PMID:
29357587
10.

A multidimensional assessment of the burden of psoriasis: results from a multinational dermatologist and patient survey.

Griffiths CEM, Jo SJ, Naldi L, Romiti R, Guevara-Sangines E, Howe T, Pietri G, Gilloteau I, Richardson C, Tian H, Augustin M.

Br J Dermatol. 2018 Jan 12. doi: 10.1111/bjd.16332. [Epub ahead of print]

PMID:
29328510
11.

Back to the Future: Looking at the Skin to Predict Death-A Lesson from Psoriasis.

Naldi L, Pezzolo E.

J Invest Dermatol. 2018 Jan;138(1):20-22. doi: 10.1016/j.jid.2017.08.027.

PMID:
29273147
12.

Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Sbidian E, Chaimani A, Garcia-Doval I, Do G, Hua C, Mazaud C, Droitcourt C, Hughes C, Ingram JR, Naldi L, Chosidow O, Le Cleach L.

Cochrane Database Syst Rev. 2017 Dec 22;12:CD011535. doi: 10.1002/14651858.CD011535.pub2. Review.

PMID:
29271481
13.

Perception of ABC (asymmetry, borders, and color) parameters in the screening for melanoma: Model exercise with experienced dermatologists.

Naldi L, Falgheri G, De Bitonto A, Di Landro A, Foiadelli L, Imberti G, Riva F, Cazzaniga S.

J Am Acad Dermatol. 2018 May;78(5):996-998. doi: 10.1016/j.jaad.2017.12.035. Epub 2017 Dec 18. No abstract available.

PMID:
29269329
14.

Prevalence of skin disease in a population-based sample of adults from five European countries.

Svensson A, Ofenloch RF, Bruze M, Naldi L, Cazzaniga S, Elsner P, Goncalo M, Schuttelaar MA, Diepgen TL.

Br J Dermatol. 2018 May;178(5):1111-1118. doi: 10.1111/bjd.16248. Epub 2018 Mar 30.

PMID:
29247509
15.

Dermatological Complications After Solid Organ Transplantation.

Naldi L, Venturuzzo A, Invernizzi P.

Clin Rev Allergy Immunol. 2018 Feb;54(1):185-212. doi: 10.1007/s12016-017-8657-9. Review.

PMID:
29177692
16.

Rituximab as first-line adjuvant therapy for pemphigus: Retrospective analysis of long-term outcomes at a single center.

Vinay K, Cazzaniga S, Amber KT, Feldmeyer L, Naldi L, Borradori L.

J Am Acad Dermatol. 2018 Apr;78(4):806-808. doi: 10.1016/j.jaad.2017.11.024. Epub 2017 Nov 13. No abstract available.

PMID:
29146127
17.

PACE study: real-life Psoriasis Area and Severity Index (PASI) 100 response with biological agents in moderate-severe psoriasis.

Carrera CG, Dapavo P, Malagoli P, Naldi L, Arancio L, Gaiani F, Egan CG, Di Mercurio M, Cattaneo A.

J Dermatolog Treat. 2017 Nov 10:1-6. doi: 10.1080/09546634.2017.1395805. [Epub ahead of print]

PMID:
29058948
18.

Evaluation of Risk of Major Adverse Cardiovascular Events With Biologic Therapy in Patients With Psoriasis.

Bissonnette R, Kerdel F, Naldi L, Papp K, Galindo C, Langholff W, Tang KL, Szapary P, Fakharzadeh S, Srivastava B, Goyal K, Gottlieb AB.

J Drugs Dermatol. 2017 Oct 1;16(10):1002-1013.

PMID:
29036254
19.

Human papillomavirus and posttransplantation cutaneous squamous cell carcinoma: A multicenter, prospective cohort study.

Bouwes Bavinck JN, Feltkamp MCW, Green AC, Fiocco M, Euvrard S, Harwood CA, Nasir S, Thomson J, Proby CM, Naldi L, Diphoorn JCD, Venturuzzo A, Tessari G, Nindl I, Sampogna F, Abeni D, Neale RE, Goeman JJ, Quint KD, Halk AB, Sneek C, Genders RE, de Koning MNC, Quint WGV, Wieland U, Weissenborn S, Waterboer T, Pawlita M, Pfister H; EPI-HPV-UV-CA group.

Am J Transplant. 2018 May;18(5):1220-1230. doi: 10.1111/ajt.14537. Epub 2017 Nov 22.

20.

No Association between Vitiligo and Obesity: A Case-Control Study.

Dragoni F, Conti R, Cazzaniga S, Colucci R, Pisaneschi L, Naldi L, Moretti S.

Med Princ Pract. 2017;26(5):421-426. doi: 10.1159/000481436. Epub 2017 Sep 12.

Supplemental Content

Support Center